Remus Pharmaceuticals Limited (NSE:REMUS)
India · Delayed Price · Currency is INR 656.30
-21.20 (-3.13%)
Jan 23, 2026, 3:27 PM IST
Remus Pharmaceuticals Market Cap
Remus Pharmaceuticals has a market cap or net worth of 7.65 billion as of January 23, 2026. Its market cap has decreased by -47.74% in one year.
Market Cap
7.65B
Enterprise Value
7.91B
Revenue
7.48B
Ranking
n/a
PE Ratio
23.98
Stock Price
656.30
Market Cap Chart
Since May 29, 2023, Remus Pharmaceuticals's market cap has increased from 2.65B to 7.65B, an increase of 189.08%. That is a compound annual growth rate of 49.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 7.90B | -3.52% |
| Dec 31, 2025 | 8.19B | -44.37% |
| Dec 31, 2024 | 14.72B | 30.53% |
| Dec 29, 2023 | 11.27B | 325.95% |
| May 29, 2023 | 2.65B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Khemani Distributors & Marketing | 3.05B |
| Vaidya Sane Ayurved Laboratories | 2.46B |
| Aptus Pharma | 1.61B |
| Achyut Healthcare | 1.32B |
| Rama Vision | 1.29B |
| Chemkart India | 1.01B |
| Novelix Pharmaceuticals | 964.60M |
| VijayPD Ceutical | 786.03M |